Central Retinal Vein Occlusion Caused by Antipsychotic Drugs: A Case Report
Journal of Ophthalmic and Optometric Sciences,
Vol. 8 No. 2 (2024),
2 April 2024
,
Page 41-43
https://doi.org/10.22037/joos.v8i2.47595
Abstract
A forty-one-year-old man suffering from schizophrenia was referred to Basir Eye Clinic, Tehran, Iran, for visual evoked potential (VEP) testing. His right eye was totally blind, whereas his left eye was barely able to distinguish light. The VEP P100 peak was absent in both eyes. A full workup of the patient revealed that he suffered from central retinal vein occlusion due to antipsychotic drugs.
- Schizophrenia
- Visual Evoked Potential
- Retinal Vein Occlusion
- Antipsychotic
- Drug
How to Cite
References
Pennington M, McCrone P. The Cost of Relapse in Schizophrenia. Pharmacoeconomics. 2017;35(9):921-36.
Loonen AJ, Ivanova SA. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia. J Psychopharmacol. 2021;35(1):3-14.
Lim CZ, Sonny Teo KS, Tai E. Olanzapine-induced Cataract in a Teenage Girl. Cureus. 2018;10(4):e2553.
Kelly DL, Conley RR, Richardson CM, Tamminga CA, Carpenter WT Jr. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Ann Clin Psychiatry. 2003;15(3-4):181-6.
Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs. 2010;24(6):501-26.
Chiang TK, White KM, Kurup SK, Yu M. Use of Visual Electrophysiology to Monitor Retinal and Optic Nerve Toxicity. Biomolecules. 2022;12(10):1390.
Sarzaeim F, Abdolalizadeh S, Shushtarian SMM, Shojaei A. Visual Evoked Potential Findings in Patients using Anti-Seizure Medicine. J Ophthalmol Res., 2022;5(3):123-6.
Taki K, Kida T, Fukumoto M, Sato T, Oku H, Ikeda T. Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs. Case Rep Ophthalmol. 2017;8(2):410-5.
- Abstract Viewed: 85 times
- pdf Downloaded: 229 times
